TrialBMC endocrine disorders2016

Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study.

Amir Farshchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.